Verastem | VSTM - Current Assets

Stock Price
5.82
Daily Change
-0.02 -0.34%
Monthly
-14.29%
Yearly
-2.51%
Q1 Forecast
5.64

Verastem reported $124.7M in Current Assets for its fiscal quarter ending in March of 2025.





Current Assets Change Date
AbbVie USD 28.54B 722M Sep/2025
Alaunos Therapeutics USD 2.68M 1.05M Sep/2025
AstraZeneca USD 28.72B 1.22B Dec/2025
Curis USD 14.42M 10.39M Jun/2025
Cytokinetics USD 977.35M 90.81M Sep/2025
Gilead Sciences USD 19.89B 1.05B Dec/2025
Incyte USD 5.02B 746.01M Dec/2025
Laboratory Of America USD 4.08B 8.4M Sep/2025
Novartis USD 28.2B 2.26B Sep/2025
Pfizer USD 46.92B 3.22B Sep/2025
Roche Holding CHF 38.73B 3.03B Dec/2025
TG Therapeutics USD 599.76M 64.2M Sep/2025
Verastem USD 124.7M 29.74M Mar/2025